Treatment AI Acquires Rocket Doctor to Enhance Digital Health

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Treatment.com AI recently announced it has entered into a Definitive Share Purchase Agreement with Rocket Doctor and the common shareholders of Rocket Doctor with respect to the proposed acquisition of 100% of the issued and outstanding securities in the capital of Rocket Doctor by Treatment. Rocket Doctor is a Canadian federally incorporated company which aims to transform the way healthcare is delivered, through empowering doctors to start their own virtual practices, thereby providing citizens with quick access to high-quality, comprehensive medical care, powered by advanced devices and proprietary technology.

Rocket Doctor is an alumnus of our BDSP™ and CAAP® programs, part of the Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence, and presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Paradox Immunotherapeutics Secures $10M Investment to Advance Therapies for Protein Misfolding Diseases
Next

OBIO® secures funding from Government of Canada to expand Canada's manufacturing capabilities and bring innovations to market